Key result
CABG cuts 5-year mortality ~43% vs. PCI in multivessel CAD with LV dysfunction.
Why the study?
Coronary artery disease and heart failure are major contributors to cardiovascular death worldwide, motivating a comparison of outcomes after CABG versus PCI in patients with CAD and LV systolic dysfunction.
Does coronary artery bypass grafting reduce short-term and long-term all-cause mortality compared with percutaneous coronary intervention in patients with multivessel coronary artery disease and left ventricular systolic dysfunction?
Meta-Analysis (n=29,554)
Yes
Does coronary artery bypass grafting reduce short-term and long-term all-cause mortality compared with percutaneous coronary intervention in patients with multivessel coronary artery disease and left ventricular systolic dysfunction?
In patients with multivessel coronary artery disease and left ventricular systolic dysfunction (LVEF <50%), CABG is associated with significantly lower 5- and 10-year mortality, 5-year MI, worsening heart failure, and repeat revascularization compared with PCI, despite an increased risk of early postoperative stroke.
Answers are grounded in this paper and cite their sources.
Supports CABG over PCI for multivessel CAD with LV dysfunction; confirms and extends RCT evidence to 10-year survival.
Background: Cardiovascular disease is the leading cause of death worldwide, with coronary artery disease (CAD) and heart failure among its major contributors. This meta-analysis aimed to compare outcomes after coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with CAD and left ventricular (LV) systolic dysfunction. Methods: The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Electronic databases were systematically searched for studies published from January 2006 to November 2025. Studies comparing CABG and PCI in patients with multivessel CAD and an LV ejection fraction <50% were eligible for inclusion. Results: The meta-analysis included 24 studies comprising 29,554 patients. CABG was associated with a higher risk of postoperative stroke (within 30 days or during hospitalization; odds ratio [OR], 1.98; 95% confidence interval [CI], 1.04-3.78; p=0.04). Perioperative mortality, myocardial infarction, and heart failure incidence were comparable between the procedures. At 5-year follow-up, CABG was associated with lower risks of mortality (OR, 0.57; 95% CI, 0.47-0.70; p<0.01), myocardial infarction (OR, 0.32; 95% CI, 0.20-0.50; p<0.01), worsening heart failure (OR, 0.48; 95% CI, 0.28-0.823; p<0.001), and repeat revascularization (OR, 0.22; 95% CI, 0.16-0.30; p<0.01). The association between CABG and lower long-term mortality remained significant at 10-year follow-up (OR, 0.71; 95% CI, 0.54-0.92; p=0.01). Conclusion: Among patients with multivessel CAD and LV systolic dysfunction, CABG was associated with lower mortality at 5 and 10 years than PCI, despite a higher risk of early postoperative stroke.
No takes yet. Share an insight, caveat, or question.
Eleftheriadis et al. (2026) conducted a meta-analysis in Multivessel coronary artery disease and left ventricular systolic dysfunction (n=29,554). Coronary artery bypass grafting (CABG) vs. Percutaneous coronary intervention (PCI) was evaluated on 5-year all-cause mortality (OR 0.57, 95% CI 0.47-0.70, p=<0.01). CABG reduced 5-year and 10-year mortality compared to PCI in multivessel CAD with LV systolic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: